MOLECULAR THERAPEUTICS OF LIVER DISEASE

Abbas, 2000, Immunology: Improving on nature in the twenty-first century, Cell, 100, 129, 10.1016/S0092-8674(00)81689-X Abrams, 1999, CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris, J Clin Invest, 103, 1243, 10.1172/JCI5857 Alison, 2000, Hepatocytes from non-hepatic adult stem cells, Nature, 406, 257, 10.1038/35018642 Ashkenazi, 1997, Immunoadhesins as research tools and therapeutic agents, Curr Opin Immunol, 9, 195, 10.1016/S0952-7915(97)80135-5 Ashkenazi, 1999, Apoptosis control by death and decoy receptors, Curr Opin Cell Biol, 11, 255, 10.1016/S0955-0674(99)80034-9 Benihoud, 1999, Adenovirus vectors for gene delivery, Curr Opin Biotechnol, 10, 440, 10.1016/S0958-1669(99)00007-5 Bergelson, 1997, Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5, Science, 275, 1320, 10.1126/science.275.5304.1320 Berns, 1995, The cryptic life style of adeno-associated virus, Bioessays, 17, 237, 10.1002/bies.950170310 Bischoff, 1996, An adenovirus mutant that replicates selectively in p53-deficient human tumor cells, Science, 274, 373, 10.1126/science.274.5286.373 Bramson, 1997, Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination, Gene Ther, 4, 1069, 10.1038/sj.gt.3300508 Brown, 1994, Gene therapy for cholesterol, Nat Genet, 7, 349, 10.1038/ng0794-349 Bukrinsky, 1993, A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells, Nature, 365, 666, 10.1038/365666a0 Chambers, 1999, Costimulatory regulation of T cell function, Curr Opin Cell Biol, 11, 203, 10.1016/S0955-0674(99)80027-1 Chang, 2000, Tp53 gene therapy: A key to modulating resistance to anticancer therapies?, Mol Med Today, 6, 358, 10.1016/S1357-4310(00)01767-6 Chen, 1995, Combination gene therapy for liver metastasis of colon carcinoma in vivo, Proc Natl Acad Sci U S A, 92, 2577, 10.1073/pnas.92.7.2577 Chowdhury, 1991, Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits, Science, 254, 1802, 10.1126/science.1722351 1997 Cole-Strauss, 1996, Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide, Science, 273, 1386, 10.1126/science.273.5280.1386 Dai, 1999, The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection, Curr Opin Immunol, 11, 504, 10.1016/S0952-7915(99)00008-4 Daly, 1999, Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease, Proc Natl Acad Sci U S A, 96, 2296, 10.1073/pnas.96.5.2296 Davern, 1998, Recurrent disease after liver transplantation, Semin Gastrointest Dis, 9, 86 Davern, 1998, Gene therapy for liver disease, Dig Dis, 16, 23, 10.1159/000016846 Deng, 1999, Gene therapy strategies to facilitate organ transplantation, Mol Med Today, 5, 400, 10.1016/S1357-4310(99)01543-9 Douglas, 1996, Targeted gene delivery by tropism-modified adenoviral vectors, Nat Biotechnol, 14, 1574, 10.1038/nbt1196-1574 Duan, 2000, A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation, Nat Med, 6, 595, 10.1038/75080 Ferber, 2000, Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia, Nat Med, 6, 568, 10.1038/75050 Ferrari, 1996, Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors, J Virol, 70, 3227, 10.1128/JVI.70.5.3227-3234.1996 Finck, 1994, Treatment of murine lupus with CTLA4Ig, Science, 265, 1225, 10.1126/science.7520604 Fisher, 1996, Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis, J Virol, 70, 520, 10.1128/JVI.70.1.520-532.1996 Follenzi, 2000, Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences, Nat Genet, 25, 217, 10.1038/76095 Fox, 1998, Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation, N Engl J Med, 338, 1422, 10.1056/NEJM199805143382004 Friedman, 2000, Mechanisms and therapy of hepatic fibrosis: Report of the AASLD single topic basic research conference, Hepatology, 32, 1403, 10.1053/jhep.2000.20243 Gorlich, 1996, Nucleocytoplasmic transport, Science, 271, 1513, 10.1126/science.271.5255.1513 Griffith, 1998, TRAIL: A molecule with multiple receptors and control mechanisms, Curr Opin Immunol, 10, 559, 10.1016/S0952-7915(98)80224-0 Grompe, 1999, Principles of therapeutic liver repopulation, Semin Liver Dis, 19, 7, 10.1055/s-2007-1007093 Grossman, 1995, A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia, Nat Med, 1, 1148, 10.1038/nm1195-1148 Grossman, 1994, Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia, Nat Genet, 6, 335, 10.1038/ng0494-335 Guinan, 1999, Transplantation of anergic histoincompatible bone marrow allografts, N Engl J Med, 340, 1704, 10.1056/NEJM199906033402202 Günzburg, 1996, Development of retroviral vectors as safe, targeted gene delivery systems, J Mol Med, 74, 171, 10.1007/BF00204747 Gupta, 1999, Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation, Semin Liver Dis, 19, 15, 10.1055/s-2007-1007094 Hayden, 1997, Antibody engineering, Curr Opin Immunol, 9, 201, 10.1016/S0952-7915(97)80136-7 Heinzinger, 1994, The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells, Proc Natl Acad Sci U S A, 91, 7311, 10.1073/pnas.91.15.7311 Hobbs, 1992, Molecular genetics of the LDL receptor gene in familial hypercholesterolemia, Hum Mutat, 1, 445, 10.1002/humu.1380010602 Ilan, 1996, Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats, J Clin Invest, 98, 2640, 10.1172/JCI119085 Ilan, 1997, Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression, Proc Nat Acad Sci U S A, 94, 2587, 10.1073/pnas.94.6.2587 Ilan, 1997, Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors, J Clin Invest, 99, 1098, 10.1172/JCI119238 Ilan, 1999, Adenovirus-mediated gene therapy of liver diseases, Semin Liver Dis, 19, 49, 10.1055/s-2007-1007097 Ivics, 1997, Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells, Cell, 91, 501, 10.1016/S0092-8674(00)80436-5 Jin, 2000, In vivo selection using a cell-growth switch, Nat Genet, 26, 64, 10.1038/79194 Jo, 2000, Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand, Nat Med, 6, 564, 10.1038/75045 Kafri, 1997, Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors, Nat Genet, 17, 314, 10.1038/ng1197-314 Kafri, 1998, Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy, Proc Nat Acad Sci U S A, 95, 11377, 10.1073/pnas.95.19.11377 Kalpana, 1999, Retroviral vectors for liver-directed gene therapy, Semin Liver Dis, 19, 27, 10.1055/s-2007-1007095 Kaneko, 1995, Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression, Cancer Res, 55, 5283 Kawai, 2000, Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand, Nat Med, 6, 114, 10.1038/72162 Kay, 1995, Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration, Nat Genet, 11, 191, 10.1038/ng1095-191 Kay, 2000, Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector, Nat Genet, 24, 257, 10.1038/73464 Kay, 1997, Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver, Proc Natl Acad Sci U S A, 94, 4686, 10.1073/pnas.94.9.4686 Kianmanesh, 1997, A “distant” bystander effect of suicide gene therapy: Regression of nontransduced tumors together with a distant transduced tumor, Hum Gene Ther, 8, 1807, 10.1089/hum.1997.8.15-1807 Klages, 2000, A stable system for the high-titer production of multiply attenuated lentiviral vectors, Molecular Therapy, 2, 170, 10.1006/mthe.2000.0103 Kobayashi, 2000, Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes, Science, 287, 1258, 10.1126/science.287.5456.1258 Kovesdi, 1997, Adenoviral vectors for gene transfer, Curr Opin Biotechnol, 8, 583, 10.1016/S0958-1669(97)80033-X Krasnykh, 2000, Genetic targeting of adenoviral vectors, Molecular Therapy, 1, 391, 10.1006/mthe.2000.0062 Krasnykh, 1996, Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism, J Virol, 70, 6839, 10.1128/JVI.70.10.6839-6846.1996 Kren, 1997, Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotide, Hepatology, 25, 1462, 10.1002/hep.510250626 Kren, 1999, Gene repair using chimeric RNA/DNA oligonucleotides, Semin Liver Dis, 19, 93, 10.1055/s-2007-1007101 Kren, 1999, Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type I with a chimeric oligonucleotide, Proc Natl Acad Sci U S A, 96, 10349, 10.1073/pnas.96.18.10349 Krieg, 2000, Minding the Cs and Gs, Molecular Therapy, 1, 209, 10.1006/mthe.2000.0041 Kühn, 1997, Advances in gene targeting methods, Curr Opin Immunol, 9, 183, 10.1016/S0952-7915(97)80133-1 Laconi, 1998, Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine, Am J Pathol, 153, 319, 10.1016/S0002-9440(10)65574-5 Lagasse, 2000, Purified hematopoietic stem cells can differentiate into hepatocytes in vivo, Nat Med, 6, 1229, 10.1038/81326 Lake, 1998, Hepatocyte transplantation, N Engl J Med, 338, 1463, 10.1056/NEJM199805143382012 Larsen, 1997, The CD40 pathway in allograft rejection, acceptance, and tolerance, Curr Opin Immunol, 9, 641, 10.1016/S0952-7915(97)80043-X Lewis, 1992, Human immunodeficiency virus infection of cells arrested in the cell cycle, EMBO J, 11, 3053, 10.1002/j.1460-2075.1992.tb05376.x Lewis, 1994, Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus, J Virol, 68, 510, 10.1128/JVI.68.1.510-516.1994 Liu, 1999, Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA, Gene Ther, 6, 1258, 10.1038/sj.gt.3300947 Lu, 1999, Regulation of self-tolerance by CD80/CD86 interactions, Curr Opin Immunol, 9, 858, 10.1016/S0952-7915(97)80190-2 Lusher, 1999, Gene therapy for hemophilia A and B: Patient selection and follow-up, requirements for a cure, Thromb Haemost, 82, 572, 10.1055/s-0037-1615882 Manley, 2000, Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke, Nat Med, 6, 159, 10.1038/72256 Manning, 1998, Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors, Hum Gene Ther, 9, 477, 10.1089/hum.1998.9.4-477 Miao, 2000, Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: Cell cycling does not influence hepatocyte transduction, J Virol, 74, 3793, 10.1128/JVI.74.8.3793-3803.2000 Miao, 1998, The kinetics of rAAV integration in the liver, Nat Genet, 19, 13, 10.1038/ng0598-13 Mignon, 1998, Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes, Nat Med, 4, 1185, 10.1038/2681 Miller, 1997, Development and applications of retroviral vectors Miller, 1990, Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection, Mol Cell Biol, 10, 4239, 10.1128/MCB.10.8.4239 Minshull, 1999, Protein evolution by molecular breeding, Curr Opin Chem Biol, 3, 284, 10.1016/S1367-5931(99)80044-1 Mitani, 1995, Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector, Proc Natl Acad Sci U S A, 92, 3854, 10.1073/pnas.92.9.3854 Morsy, 1999, Expanded-capacity adenoviral vectors–the helper-dependent vectors, Mol Med Today, 5, 18, 10.1016/S1357-4310(98)01376-8 Nakai, 2000, Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors, Nat Biotechnol, 18, 527, 10.1038/75390 Naldini, 1996, In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science, 272, 263, 10.1126/science.272.5259.263 Overturf, 1996, Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I, Nat Genet, 12, 266, 10.1038/ng0396-266 Park, 2000, Efficient lentiviral transduction of liver requires cell cycling in vivo, Nat Genet, 24, 49, 10.1038/71673 Parks, 1996, A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal, Proc Natl Acad Sci U S A, 93, 13565, 10.1073/pnas.93.24.13565 Patijn, 1999, Hepatic gene therapy using adeno-associated virus vectors, Semin Liver Dis, 19, 61, 10.1055/s-2007-1007098 Patten, 1997, Applications of DNA shuffling to pharmaceuticals and vaccines, Curr Opin Biotechnol, 8, 724, 10.1016/S0958-1669(97)80127-9 Peng, 1999, Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung, J Virol, 73, 5098, 10.1128/JVI.73.6.5098-5109.1999 Petersen, 1999, Bone marrow as a potential source of hepatic oval cells, Science, 284, 1168, 10.1126/science.284.5417.1168 Pleyer, 2000, Immune tolerance and gene therapy in transplantation, Immunol Today, 21, 12, 10.1016/S0167-5699(99)01546-7 Ponnazhagan, 1997, Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice, Gene, 190, 203, 10.1016/S0378-1119(96)00576-8 Qing, 1998, Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo, J Virol, 72, 1593, 10.1128/JVI.72.2.1593-1599.1998 Reiser, 1996, Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases, N Engl J Med, 335, 1369, 10.1056/NEJM199610313351807 Rhim, 1994, Replacement of diseased mouse liver by hepatic cell transplantation, Science, 263, 1149, 10.1126/science.8108734 Rother, 1995, A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody, J Exp Med, 182, 1345, 10.1084/jem.182.5.1345 Rudolph, 2000, Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery [see comments], Science, 287, 1253, 10.1126/science.287.5456.1253 Ruiz, 1999, Gene therapy of viral hepatitis and hepatocellular carcinoma, J Viral Hepat, 6, 17, 10.1046/j.1365-2893.1999.6120136.x Russell, 1998, Human gene targeting by viral vectors, Nat Genet, 18, 325, 10.1038/ng0498-325 Saez, 1997, Inducible gene expression in mammalian cells and transgenic mice, Curr Opin Biotechnol, 8, 608, 10.1016/S0958-1669(97)80037-7 Samulski, 1991, Targeted integration of adeno-associated virus (AAV) into human chromosome 19, EMBO J, 10, 3941, 10.1002/j.1460-2075.1991.tb04964.x Sayegh, 1998, The role of T-cell costimulatory activation pathways in transplant rejection, N Engl J Med, 338, 1813, 10.1056/NEJM199806183382506 Schiedner, 1998, Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity, Nat Genet, 18, 180, 10.1038/ng0298-180 Shenk, 1996, Adenoviridae: The viruses and their replication, 2111 Snyder, 1999, Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors, Nat Med, 5, 64, 10.1038/13518 Snyder, 1997, Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors, Nat Genet, 16, 270, 10.1038/ng0797-270 Soong, 2000, Molecular breeding of viruses, Nat Genet, 25, 436, 10.1038/78132 Strom, 1999, Hepatocyte transplantation for the treatment of human disease, Semin Liver Dis, 19, 39, 10.1055/s-2007-1007096 Sun, 2000, Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization, Nat Med, 6, 599, 10.1038/75087 Takahashi, 1996, Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period, J Biol Chem, 271, 26536, 10.1074/jbc.271.43.26536 Tanaka, 2000, Expression and antitumor effects of TRAIL in human cholangiocarcinoma, Hepatology, 32, 523, 10.1053/jhep.2000.9716 Teichler Zallen, 2000, US gene therapy in crisis, Trends Genet, 16, 272, 10.1016/S0168-9525(00)02025-4 Theise, 2000, Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation, Hepatology, 31, 235, 10.1002/hep.510310135 Tilg, 2000, Cytokines in alcoholic and nonalcoholic steatohepatitis, N Engl J Med, 343, 1467, 10.1056/NEJM200011163432007 Van Antwerp, 1998, Inhibition of TNF-induced apoptosis by NF-kappa B, Trends in Cell Biology, 8, 107, 10.1016/S0962-8924(97)01215-4 White, 1995, Regulation of p53-dependent apoptosis by E1A and E1B, Curr Top Microbiol Immunol, 199, 34 Wickham, 1993, Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment, Cell, 73, 309, 10.1016/0092-8674(93)90231-E Wold, 1999, Immune responses to adenoviruses: Viral evasion mechanisms and their implications for the clinic, Curr Opin Immunol, 11, 380, 10.1016/S0952-7915(99)80064-8 Wood, 1997, Gene therapy and allotransplantation, Curr Opin Immunol, 9, 662, 10.1016/S0952-7915(97)80046-5 Xiao, 1998, Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus, J Virol, 72, 2224, 10.1128/JVI.72.3.2224-2232.1998 Yamanaka, 2000, Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines, Hepatology, 32, 482, 10.1053/jhep.2000.16266 Yant, 2000, Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system, Nat Genet, 25, 35, 10.1038/75568 Ye, 1998, Targeted gene correction: A new strategy for molecular medicine, Mol Med Today, 4, 431, 10.1016/S1357-4310(98)01344-6 Yew, 2000, Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs, Molecular Therapy, 1, 255, 10.1006/mthe.2000.0036 Young, 2000, Biomedical discovery with DNA arrays, Cell, 102, 9, 10.1016/S0092-8674(00)00005-2 Zemlo, 2000, The physician-scientist: Career issues and challenges at the year 2000, FASEB J, 14, 221, 10.1096/fasebj.14.2.221 Zhang, 1999, High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA, Hum Gene Ther, 10, 1735, 10.1089/10430349950017734 Zweiger, 1997, From expressed sequence tags to `epigenomics': An understanding of disease processes, Curr Opin Biotechnol, 8, 684, 10.1016/S0958-1669(97)80119-X